Therapeutic options for mucinous ovarian carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic options for mucinous ovarian carcinoma

Published:2020-03 Issue:3 Volume:156 Page:552-560
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Gorringe Kylie L.^ORCID,Cheasley Dane,Wakefield Matthew J.,Ryland Georgina L.,Allan Prue E.,Alsop Kathryn,Amarasinghe Kaushalya C.,Ananda Sumitra,Bowtell David D.L.,Christie Michael,Chiew Yoke-Eng,Churchman Michael^ORCID,DeFazio Anna^ORCID,Fereday Sian,Gilks C. Blake,Gourley Charlie,Hadley Alison M.,Hendley Joy,Hunter Sally M.,Kaufmann Scott H.,Kennedy Catherine J.,Köbel Martin^ORCID,Le Page Cecile^ORCID,Li Jason,Lupat Richard,McNally Orla M.,McAlpine Jessica N.,Pyman Jan,Rowley Simone M.,Salazar Carolina,Saunders Hugo,Semple Timothy,Stephens Andrew N.,Thio Niko,Torres Michelle C.,Traficante Nadia,Zethoven Magnus,Antill Yoland C.,Campbell Ian G.,Scott Clare L.

Funder

National Health and Medical Research Council

Victorian Cancer Agency

Cancer Council Victoria

Peter MacCallum Cancer Foundation

Stafford Fox Medical Research Foundation

Australian Cancer Research Foundation

Victorian State Government Operational Infrastructure Support

NHMRC

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference46 articles.

1. Clinicopathological characteristics of mucinous adenocarcinoma of the ovary;Shimada;Gynecol. Oncol.,2009

2. Risk factors for epithelial ovarian cancer by histologic subtype;Gates;Am. J. Epidemiol.,2010

3. Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: cell type is the most useful prognostic factor;Bamias;Eur. J. Cancer,2011

4. Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer;Mackay;Int. J. Gynecol. Cancer,2010

5. An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor;Gore;Gynecol. Oncol.,2019

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular alterations in mucinous ovarian tumors – a review;Current Issues in Pharmacy and Medical Sciences;2024-09-01

2. Diagnostic difficulties in the differentiation between an ovarian metastatic low‑grade appendiceal mucinous neoplasm and primary ovarian mucinous cancer: A case report and literature review;Oncology Letters;2024-08-16

3. A new method for network bioinformatics identifies novel drug targets for mucinous ovarian carcinoma;NAR Genomics and Bioinformatics;2024-07-02

4. HER2-low and Overexpression in Mucinous Ovarian Cancer: Analysis of ASCO/CAP and ToGA Immunohistochemical Scoring;International Journal of Gynecological Pathology;2024-03-04

5. New windows of surgical opportunity for gynecological cancers in the era of targeted therapies;International Journal of Gynecologic Cancer;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3